Antimicrobial resistance in nontyphoid Salmonella serotypes: A global challenge

Clinical Infectious Diseases

Volumn 39, Issue 4, 2004, Pages 546-551

  Su, Lin Hui ^a   Chiu, Cheng Hsun ^a,b   Chu, Chishih ^a   Ou, Jonathan T ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; VIRULENCE FACTOR;

ANIMAL FOOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM DETECTION; DRUG USE; GENE CASSETTE; GENETIC ANALYSIS; HORIZONTAL GENE TRANSFER; HUMAN; INCIDENCE; LABORATORY TEST; LIVESTOCK; MOLECULAR EVOLUTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA HADAR; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; TAIWAN;

ANIMALS; DRUG RESISTANCE, MICROBIAL; HUMANS; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA TYPHI; SEROTYPING; TYPHOID FEVER;

EID: 4344620834     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/422726     Document Type: Review

References (42)

1. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. Increase in antimicrobial-resitant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994; 170:128-34.
2. Tassios PT, Markogiannakis A, Vatopoulos AC, et al. Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece. J Clin Microbiol 1997; 35:1316-21.
3. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998; 26:341-5.
4. Yildirmak T, Yazgan A, Ozcengiz G. Multuple drug resistance patterns and plasmid profiles of non-typhi salmonellae in Turkey. Epidemiol Infect 1998; 121:303-7.
5. Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist 1997; 3:263-6.
6. Davis MA, Hancock DD, Besser TE, et al. Changes in antimicrobial resistance among Salmonella enterica serovar Typhimurium isolates from humans and cattle in the northwestern United States, 1982-1997. Emerg Infect Dis 1999; 5:802-6.
7. Breuil J, Brisabois A, Casin I, Armand-Lefevre L, Fremy S, Collatz E. Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother 2000; 46:965-71.
8. Nastasi A, Mammina C, Cannova L. Antimicrobial resistance in Salmonella enteritidis, southern Italy, 1990-1998. Emerg Infect Dis 2000; 6:401-3.
9. Cruchaga S, Echeita A, Aladuena A, Garcia-Pena J, Frias N, Usera MA. Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J Antimicrob Chemother 2001; 47:315-21.
10. Mølbak K, Baggesen DL, Aarestrup FM, et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med 1999; 341:1420-5.
11. Threlfall EJ, Ward LR, Rowe B. Multiresistant Salmonella typhimurium DT 104 and bacteraemia. Lancet 1998; 352:287-8.
12. Dunne EF, Fey PD, Kludt P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 2000; 284:3151-6.
13. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med 2000; 342: 1242-9.
14. Threlfall EJ, Fisher IS, Berghold C, et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill 2003; 8:41-5.
15. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003; 37:75-9.
16. Hakanen A, Kotilanien P, Jalava J, et al. Detection of increased fluoroquinolone susceptibility in Salmoenlla and validation of nalidixic acid screening test. J Clin Microbiol 1999; 37:3572-7.
17. Su LH, Chiu CH, Kuo AJ, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect 2001; 127: 207-13.
18. Chiu CH, Wu TL, Su LH, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002; 346:413-9.
19. Chiu CH, Su LH, Chu C, et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004; 363:1285-6.
20. Cloeckaert A, Chaslus-Dancla E. Mechanisms of quinolone resistance in Salmonella. Vet Res 2001; 32:291-300.
21. Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist 2002; 8:281-9.
22. Hsueh PR, Teng LJ, Tseng SP, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 2004; 10:60-8.
23. Su LH, Chiu CH, Chu C, Wang MH, Chia JH, Wu TL. In-vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype Anatum. Antimicrob Agents Chemother 2003; 47:563-7.
24. Allen KJ, Poppe C. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by β-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can J Vet Res 2002; 66:137-44.
25. Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob Agents Chemother 2000; 44:2777-83.
26. Makanera A, Arlet G, Gautier V, Manai M. Molecular epidemiology and characterization of plasmid-encoded β-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins. J Clin Microbiol 2003; 41: 2940-5.
27. DHA-1 gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother 2000; 44:222-5.
28. Chu C, Chiu CH, Wu WY, Chu CH, Liu TP, Ou JT. Large drug resistance virulence plasmids of clinical isolates of Salmonella enterica serovar Choleraesuis. Antimicrob Agents Chemother 2001; 45: 2299-303.
29. Guerra B, Soto SM, Argüelles JM, Mendoza MC. Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-]. Antimicrob Agents Chemother 2001; 45:1305-8.
30. Guerra B, Soto S, Helmuth R, Mendoza MC. Characterization of a self-transferable plasmid from Salmonella enterica serotype Typhimurium clinical isolates carrying two integron-borne gene cassettes together with virulence and drug resistance genes. Antimicrob Agents Chemother 2002; 46:2977-81.
31. Lianes C, Kirchgesner V, Plesiat P. Propagation of TEM- and PSE-type β-lactamases among amoxicillin-resistant Salmonella spp. isolated in France. Antimicrob Agents Chemother 1999; 43:2430-6.
32. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002; 34(Suppl 3):S93-106.
33. Swartz MN. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis 2002; 34(Suppl 3):S111-22.
34. McDonald LC, Chen MT, Lauderdale TL, Ho M. The use of antibiotics critical to human medicine in food-producing animals in Taiwan. J Microbiol Immunol Infect 2001; 34:97-102.
35. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999; 43:2131-7.
36. Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promoters on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001; 45:2054-9.
37. Evans MC, Wegener HC. Antimicrobial growth promoters and Salmonella spp., Campylobacter spp. in poultry and swine, Denmark. Emerg Infect Dis 2003; 9:489-92.
38. NCCLS. Performance standards for antimicrobial susceptibility testing: thirteenth informational supplement. NCCLS document M100-S13. Villanova, PA: NCCLS, 2003.
39. Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8:490-5.
40. Barza M, Travers K. Excess infections due to antimicrobial resistance: the "Attributable Fraction." Clin Infect Dis 2002; 34(Suppl 3):S126-30.
41. Howard DH, Scott RD II, Packard R, Jones D. The global impact of drug resistance. Clin Infect Dis 2003; 36(Suppl 1):S4-10.
42. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003; 47:1297-300.